Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations
Therapie. 2014 Jul-Aug;69(4):355-66.
doi: 10.2515/therapie/2014045.
Epub 2014 Aug 8.
[Article in
English,
French]
Authors
Mathieu Molimard
1
, Corine Bernaud
2
, Philippe Lechat
3
; participants of round table n6 of Giens XXIX: Bejan-Angoulvant Theodora 4 Benattia Cherif 5 Benkritly Amel 6; Theodora Bejan-Angoulvant
4
, Cherif Benattia
5
, Amel Benkritly
6
, David Braunstein
7
, Sandrine Cabut
8
, Nadine David
9
, Annie Fourrier-Réglat
10
, Benoit Gallet
11
, Marta Gersberg
12
, Sylvia Goni
13
, Pascale Jolliet
14
, Véronique Lamarque-Garnier
15
, Claire Le Jeunne
16
, Irina Leurs
17
, François Liard
18
, Muriel Malbezin
19
, Joelle Micallef
7
, Marina Nguon
20
Affiliations
- 1 CHU et Université de Bordeaux, Département de pharmacologie, Bordeaux, France.
- 2 Laboratoire AstraZeneca France, Direction médicaleRueil-Malmaison, France.
- 3 AP-HP, Département de la recherche clinique et du développement, Hôpital Saint Louis, Paris, France.
- 4 CHU de Tours, Tours, France.
- 5 Sunivion Pharmaceuticals, MarlboroughMA, USA.
- 6 Laboratoire Sanofi Aventis, Paris, France.
- 7 CIC, CPCET, CHU Timone, AP-HM, Marseille, France.
- 8 Le Monde, Paris, France.
- 9 Direction générale de la santé, Paris, France.
- 10 Université de Bordeaux, Bordeaux, France.
- 11 Laboratoire Bristol Myers Squibb, Paris, France.
- 12 MGersberg Conseil, Chatou, France.
- 13 Laboratoire Lundbeck, Issy les Moulineaux, France.
- 14 CHU, Nantes, France.
- 15 SFPT, Croissy sur Seine, France.
- 16 Hotel Dieu, AP-HP, Paris, France.
- 17 Laboratoire Norgine, Rueil Malmaison, France.
- 18 Cabinet médical, Saint Epain, France.
- 19 Laboratoire Janssen Cilag, Issy les Moulineaux, France.
- 20 Hôpital Saint Louis, AP-HP, Paris, France.
Abstract
Recent drug crises have highlighted the complexity, benefits and risks of medication communication. The difficulty of this communication is due to the diversity of the sources of information and the target audience, the credibility of spokespersons, the difficulty to communicate on scientific uncertainties and the precautionary principle, which is influenced by variable perceptions and tolerances of the risk. Globally, there is a lack of training in risk management with a tendency of modern society to refuse even the slightest risk. Communication on medications is subject to regulatory or legal requirements, often uses tools and messages that are not adapted to the target audience and is often based on a poor knowledge of communication techniques. In order to improve this situation, the available information must be coordinated by reinforcing the unique medication information website and by coordinating communication between authorities by means of a single spokesperson. A particular effort must be made in the field of training in the proper use and risk of medications for both the general population and patients but also for healthcare professionals, by setting up a unified academic on-line teaching platform for continuing medical education on medications and their proper use.
© 2014 Société Française de Pharmacologie et de Thérapeutique.
MeSH terms
-
Communication Barriers
-
Databases, Factual
-
Drug Information Services
-
Drug-Related Side Effects and Adverse Reactions*
-
Education, Medical, Continuing
-
Guidelines as Topic
-
Health Education*
-
Health Personnel / education*
-
Health Services Needs and Demand
-
Humans
-
Inappropriate Prescribing / prevention & control
-
Information Dissemination*
-
Information Seeking Behavior
-
Risk Management
-
Risk Reduction Behavior
-
Truth Disclosure